Future landscape of obesity pharmacotherapy. Ongoing trials with Download Scientific Diagram CagrisSema is a once weekly injection of semaglutide and cagrilintide. Phase 2 clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a promising Understanding Cagrilintide: Benefits and Uses TikTok Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3 eBioMedicine What is Cagrilintide? Tydes Cagrilintide is a long acting amylin analog that regulates appetite, gastric emptying, and glucagon secretion to treat obesity and related metabolic disorders. There are 2 pathways cagrilintide works: #1 is the Amylin pathway